Abbott Laboratories
Search results
Jun 25, 2024 · U.S. Food and Drug Administration (FDA) issues Complete Response Letter (CRL) for ABBV-951 based on observations from an inspection that did not involve ABBV-951 at one of AbbVie's third-party manufacturing facilities.
Jun 20, 2024 · How AbbVie is bringing antiviral expertise to the COVID-19 battle. At the first sign of the pandemic, AbbVie began evaluating ways to help, including accelerating discovery efforts and external collaborations.
4 days ago · Stock analysis for AbbVie Inc (ABBV:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Jun 25, 2024 · AbbVie Inc. failed to win approval for a new Parkinson’s disease drug after US regulators found problems at a third-party manufacturing facility.
4 days ago · AbbVie stock price quote (NYSE: ABBV), historical charts, related news, stock analyst insights and more to help you make the right investing decisions.
Jun 13, 2024 · FutureGen has utilized STEP to develop CLDN18.2 antibody-dependent cellular cytotoxicity (ADCC) enhanced antibody (FG-M108), a potential best-in-class product with excellent efficacy and superior safety in the first-line treatment of advanced G/GEJ and pancreatic cancer, currently in Phase 3.
Jun 27, 2024 · Celsius' lead investigational asset is CEL383, a potential first-in-class anti-TREM1 antibody that has completed a Phase 1 clinical study for the treatment of IBD. TREM1 has been identified as a...
